Evaluation of conventional troponin I testing for the detection of myocardial dysfunction in children

Eimear McGovern1, Christine Voss1, Nicole M Hemphill1

  • 1Division of Cardiology, Department of Pediatrics, British Columbia Children's Hospital, Vancouver, British Columbia.

Paediatrics & Child Health
|November 16, 2022
PubMed

Insights

Troponin I testing in children shows low sensitivity for detecting myocardial dysfunction, indicating limited utility as a screening tool for myocardial injury in this population.

Area of Science:

  • Pediatric Cardiology
  • Biomarkers in Cardiovascular Disease
  • Pediatric Critical Care Medicine

Background:

  • Troponin is a key biomarker for myocardial injury, but its role in pediatric populations is not extensively studied.
  • Assessing myocardial dysfunction in children requires accurate diagnostic tools.

Purpose of the Study:

  • To determine the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of troponin I for detecting acute myocardial dysfunction in previously healthy children.
  • To identify clinical predictors of myocardial dysfunction in pediatric patients with elevated troponin levels.

Main Methods:

  • A retrospective chart review was conducted at a single pediatric tertiary care center over a 4-year period.
  • Data collected included demographics, symptoms, clinical signs, chest X-ray, ECG, and echocardiogram findings for all admitted children who underwent troponin testing.
  • Myocardial dysfunction was defined based on cardiac assessment, echocardiography, and patient re-presentation.

Main Results:

  • Of 566 children tested, troponin was elevated in 6.7% (38 cases), and myocardial dysfunction was detected in 1.6% (9 cases).
  • Troponin I demonstrated a sensitivity of 66% and a specificity of 94% for detecting myocardial dysfunction.
  • The positive predictive value (PPV) was 16%, and the negative predictive value (NPV) was 99%. An abnormal ECG was associated with true positive troponin results.

Conclusions:

  • Troponin I testing identified a small number of pediatric myocardial dysfunction cases, with a sensitivity of 66%.
  • The low sensitivity and PPV suggest that troponin testing has limited utility as a routine screen for myocardial injury in children.
  • Further research may be needed to explore alternative biomarkers or diagnostic strategies for pediatric myocardial dysfunction.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
232
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
20
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
19
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
46
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
58
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.2K